TGFB1 and lung carcinoma: Thus, the incorporation of TGF-β nuclear staining as a potential prognostic factor of resectable lung cancer should be studied in future work to confirm whether it may represent a viable powerful tool for the identification of patients with a high risk of recurrence being priority candidates for adjuvant treatment with ICIs and TGF-β inhibitors.